- Communication
Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age
- Raffaella Calabretta,
- Philipp B. Staber,
- Christoph Kornauth,
- Xia Lu,
- Patrick Binder,
- Verena Pichler,
- Markus Mitterhauser,
- Alexander Haug,
- Xiang Li and
- Marcus Hacker
Background: Immune checkpoint inhibitors (ICI) have transformed the management of various cancers. Serious and potentially fatal cardiovascular toxicity, as well as a progression of atherosclerosis, have been described, mainly in elderly and comorbid...

